MONTANOVA CAPITAL, LLC CMPX COMPASS THERAPEUTICS INC

Ownership history in MONTANOVA CAPITAL, LLC  ·  5 quarters on record

AI Ownership Summary

MONTANOVA CAPITAL, LLC reported COMPASS THERAPEUTICS INC (CMPX) in 5 quarterly 13F filings from 2025 Q2 through 2026 Q2. Peak portfolio weight reached 1.93% in 2026 Q1. The latest visible filing shows CMPX at 0.56% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this CMPX ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was MONTANOVA CAPITAL, LLC's position in COMPASS THERAPEUTICS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

CMPX was reported at 0.56% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
1.93% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2025 Q2 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How MONTANOVA CAPITAL, LLC held CMPX — position size vs. price
% of Fund (quarterly)    CMPX price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 5 quarters  
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 REDUCED 14,101,159 -206,220 -1.4% 0.56% $30.9M 2026-08-14 $2.25
2026 Q1 ADDED 14,307,379 +125,000 +0.9% 1.93% $75.7M 2026-05-15 $1.86
2025 Q4 ADDED 14,182,379 +81,220 +0.6% 1.56% $76.2M 2026-02-17 $6.39
2025 Q3 ADDED 14,101,159 +6,951,666 +97.2% 1.26% $49.4M 2025-11-14 $4.83
2025 Q2 INITIATED 7,149,493 0.56% $18.6M 2025-08-14 $2.95

FAQ About MONTANOVA CAPITAL, LLC and CMPX

These are the practical questions this page is built to answer before you even open the full history table.

How long has MONTANOVA CAPITAL, LLC reported owning CMPX?

MONTANOVA CAPITAL, LLC reported CMPX across 5 quarterly 13F filings, from 2025 Q2 through 2026 Q2.

What was the largest reported CMPX position in MONTANOVA CAPITAL, LLC's portfolio?

The largest reported portfolio weight for CMPX was 1.93% in 2026 Q1.

What is the latest reported CMPX position on this page?

The most recent filing on this page is 2026 Q2, when MONTANOVA CAPITAL, LLC reported 14,101,159 shares, equal to 0.56% of portfolio, with an estimated market value of $30.9M.

What does the chart on this CMPX ownership page compare?

The chart compares MONTANOVA CAPITAL, LLC's quarterly CMPX portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did MONTANOVA CAPITAL, LLC time their CMPX position?

Based on 13F filing dates vs. subsequent CMPX price moves, MONTANOVA CAPITAL, LLC correctly timed 3 out of 4 reported position changes (75%). The annualised alpha on CMPX relative to SPY over the holding period was -37.4%.

← Back to MONTANOVA CAPITAL, LLC Holdings